Science Market Update

Cancer Immunotherapy Thriving at University of Cincinnati

Posted by Sam Asher on Thu, Apr 18, 2013

The University of Cincinnati is making great progress in the field of cancer immunotherapy, developing both an oral vaccine for breast cancer and a vaccine for lung cancer in quick succession. Using unique approaches in both solutions, research teams have overcome some previous obstacles in the field to move forward and fight cancer on multiple fronts.

Read More

Tags: 2014, Midwest, 2013, Ohio, University of Cincinnati, BioResearch Product Faire Event, Cincinnati, OH, UCinci

UCSD Research Lab Invents Biomimetic Nanosponge Disguised as Red Blood Cell

Posted by Jaimee Saliba on Wed, Apr 17, 2013

Bioengineers at the University of California San Diego have come up with a novel way of removing dangerous toxins from the bloodstream using biomimetic nanosponges. These tiny clean-up particles work by posing as red blood cells, which serves both to evade the body's immune system response to foreign invaders and to attract the toxins to themselves instead of to actual red blood cells. When the toxins have all attached themselves to the nanosponges, they are processed out through the liver without harming the body. The research into this promising therapy comes out of the Zhang Lab in the Jacobs School of Engineering, where in 2011 they pioneered the red blood cell disguise technology for cloaking cancer drug cocktails, allowing the drugs much more time in the body to target diseased cells. Dr. Liangfang Zhang is also on the research faculty of the UCSD Moores Cancer Center.

Read More

Tags: 2014, CA, University of California San Diego, 2013, nanoparticle, Nanobiotechnology, nanotechnology, Nanoscience, Southwest, California, University of California, Cell Research, San Diego, SDVS, UCSD, Biotechnology Vendor Showcase

Hutch Cancer Research Center and UW Recruit Top Neuroscientist to Seattle

Posted by Jaimee Saliba on Fri, Apr 12, 2013


brain cancer researchThe Fred Hutchinson Cancer Research Center
and the University of Washington Medicine in Seattle are pleased to announce the arrival soon of Dr. Eric Holland, a world-class brain cancer research scientist and neurosurgeon, who will head up the Human Biology Division at Hutch as well as the Alvord Brain Tumor Center at UW. The eminent MD/PhD is being lured away from Manhattan's Memorial Sloan-Kettering Cancer Center, where he directs the MSKCC brain tumor center and has his lab within the Cancer Biology and Genetics Program, where his team studies the molecular mechanisms underlying the development of central nervous system tumors. In addition to being the recipient of many prestigious awards over years, Holland brings with him over $3M a year in NIH/NCI funding. It's unclear how many of his 13 lab members will follow him across the country to take on new challenges at Hutch and UW.

Read More

Tags: 2014, 2013, Northeast, Fred Hutchinson Cancer Research Center, Washington, UW, University of Washington, WA, Northwest, cancer research, Memorial Sloan-Kettering Cancer Center, brain research, Neuroscience, BioResearch Product Faire Event, Funding, Front Line event, Seattle, Frontline Event, Hutch, Cancer Center

MSU Research Shows Fish Oil Can Increase Immunity

Posted by Sam Asher on Thu, Apr 11, 2013

By this point, most Americans are familiar with the gelatinous yellow pill harked by many as a critically necessary supplement. Fish oil pills, packed with omega-3 fatty acids, are sold in many grocery stores and can be found in even more households nationwide. At Michigan State University, bioresearchers are delving deeper into the effects of fish oil on the body. What they have found may sound a little surprising at first: fish oil can increase immunity in people with certain health conditions.

Read More

Tags: Michigan State University, 2014, Midwest, 2013, fish oil, immunity, Michigan, BioResearch Product Faire Event, MI, Research, Front Line event, East Lansing, MSU, laboratory suppliers

Green Chemistry Synthesis Uses Mechanics Rather Than Solvents

Posted by Jaimee Saliba on Wed, Apr 10, 2013

green chemistry reagentGreen chemistry refers to a number of processes and practices that minimize the toxic or hazardous effects of chemicals in the environment, the lab, or the manufacturing plant. One way to go green is to cut down on the use of dangerous solvents in reactive processes, thereby reducing waste and improving lab safety. Though sometimes a less toxic catalyst or reagent can be employed from the outset, reused, or made inert eventually, another way to get a chemical reaction is to apply physical force instead. Called mechanochemistry, it involves the application of mechanical engineering to chemistry. Instead of adding a solvent, agitation is used to achieve chemical synthesis.

Read More

Tags: 2014, Midwest, 2013, Ohio, University of Cincinnati, catalysts, green chemistry, chemistry research, BioResearch Product Faire Event, Cincinnati, lab research, OH, UCinci, NSF, UC, green chemistry shows, green chem

Human Stem Cell Mechanisms Better Understood by UNC Chapel Hill Study

Posted by Jennifer Nieuwkerk on Tue, Apr 09, 2013

Read More

Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Human Stem Cell, Southern, BioResearch Product Faire Event, Research Funding, Stem Cell, Front Line event, NIH, NC, Front Line, laboratory equipment, Chapel Hill, NSF, UNC, laboratory equipment sales, UNC-Chapel Hill

Emory University Physician Honored for Cancer Research

Posted by Jennifer Nieuwkerk on Mon, Apr 08, 2013

Emory University physician and deputy director of the Winship Cancer Institute of Emory University Fadlo R. Khuri, MD, will be awarded the prestigious Richard and Hinda Rosenthal Memorial Award from the American Association for Cancer Research. The award will recognize his groundbreaking accomplishments and contributions as a researcher of lung and aerodigestive medical oncology.

Read More

Tags: 2014, Emory University, 2013, Southern, Georgia, Emory, BioResearch Product Faire Event, Research Funding, Atlanta, GA, laboratory equipment sales

$5.3M in New NIH Funding for UCLA and UCD Autism Research Centers

Posted by Jaimee Saliba on Fri, Apr 05, 2013

The NIH has just announced $5.3M in two new awards through the Autism Centers of Excellence (ACE) program to support autism research studies led by two University of California investigative teams, at UCLA and the UC Davis Medical Center MIND Institute. ACE funding is earmarked for large, multi-disciplinary studies into the origins of autism spectrum neurological disorders and avenues for their treatment. In the case of the two latest awardees, one is a clinical behavioral study and one is a study of genetic variants. The $5.3M is initial one-year funding, with extensions of up to five years. The ACE program includes both centers and networks. Centers are made up of multiple investigators at one site working together on a specific research problem; networks include investigative teams from different sites engaged in a focused study. Both UCLA and UC Davis are ACE centers and will lead the current research projects, though in collaboration with colleagues at other research institutions, namely Harvard, UW, Vanderbilt, Emory, Johns Hopkins, and Yale. As with all ACE research, data and findings are collected centrally by the NIH to maximize their availability to the larger research community.

Read More

Tags: 2014, CA, 2013, Southwest, Los Angeles, Autism, LAVS, UCDMC, BioResearch Product Faire Event, Funding, UCLA, Genetics, Research, Sacramento, Davis, NIH funding, UC Los Angeles, UC Davis, Biotechnology Vendor Showcase Event

Biochemicals From the Deep Target Tuberculosis

Posted by Sam Asher on Thu, Apr 04, 2013

When it comes to developing drugs for disease prevention and treatment, sometimes it is best not to reinvent the wheel- especially when nature holds so many solutions to those enterprising (or fortunate) individuals who know where to look.  One such researcher, Professor Brian Murphy of the University of Illinois, Chicago, collects hundreds of possibly curative species of bacteria from one of nature’s least explored resources: the floors of lakes and oceans.

Read More

Tags: 2014, Midwest, 2013, University of Illinois, tuberculosis, biochemicals, BioResearch Product Faire Event, Chicago, IL, UIChgo, actinomycete

Emory University Hospital Allows Public Cord Blood Banking

Posted by Jennifer Nieuwkerk on Tue, Apr 02, 2013

After the birth of a child at Emory University Hospital, patients will have the option of donating their umbilical cord blood, at no cost, to a bank that could help save a number of people’s lives. The cord blood can be used to treat blood diseases and disorders, such as leukemia. According to the Emory University News Center, about 20,000 people suffer from life-threatening blood disorders every year, and the banked cord blood could have an enormous impact on their treatment. Normally, umbilical cords are disposed of after a birth. Now at Emory University Hospital, women who are at least 34 weeks pregnant and expecting a single baby are eligible to bank cord blood. They will not be asked to pay a fee or monetary donation.

Read More

Tags: 2014, Emory University, 2013, cord blood banking, Southern, Georgia, Emory, BioResearch Product Faire Event, Research Funding, Atlanta, GA, lab supplier, life science equipment sales

Subscribe to Company News